Iranian health officials are raising concerns over the accessibility of the influenza vaccine, as high costs prevent many citizens from obtaining it. The influenza vaccine has become increasingly expensive, reaching prices as high as 920,000 tomans, putting it out of reach for many families. This issue particularly affects children, who represent the largest group vulnerable to the virus.
Mohammad Jamalian, a member of the Iranian Parliament’s Health and Treatment Committee, emphasized that the high price limits public access to this critical preventive measure. He noted that the influenza vaccine is not included in the country’s mandatory immunization schedule. Instead, the vaccine is sold on the open market, requiring individuals to pay out of pocket.
According to recent health reports, influenza cases have been rising across multiple regions of Iran. Hospitals and clinics have reported increasing admissions, especially among young children and elderly patients. Experts warn that limited vaccination coverage could exacerbate seasonal outbreaks and place additional strain on healthcare facilities.
Jamalian highlighted that while some families can afford the influenza vaccine, a significant portion of the population struggles financially. This disparity underscores the need for government intervention to ensure broader access to vaccines. He urged policymakers to consider subsidizing the vaccine or including it in national immunization programs.
In addition to affordability, the distribution of influenza vaccines also faces logistical challenges. Pharmacies in smaller towns often have limited stock, while urban areas experience high demand. Health authorities have called for improved supply chains and public awareness campaigns to encourage timely vaccination.
Experts argue that expanding access to the influenza vaccine could significantly reduce illness and hospitalization rates. They stress that vaccination remains the most effective preventive tool against seasonal influenza. In parallel, healthcare providers are advising families to maintain hygiene practices and seek medical guidance promptly if flu symptoms appear.
Looking ahead, officials plan to evaluate potential subsidies and policy adjustments. These measures aim to improve vaccination rates and protect vulnerable populations. The ongoing discussions highlight the intersection of public health, economic policy, and social equity in Iran’s healthcare system.
The debate over influenza vaccine access also reflects wider challenges in ensuring preventive healthcare affordability. Observers note that addressing these issues could serve as a model for managing other essential vaccines and medicines in the country.